v3.26.3
Condensed Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]                
Net Assets at Beginning of period $ 355,856,986 $ 361,551,582 $ 205,316,251 $ 219,409,595 $ 156,804,155 $ 157,572,086 $ 205,316,251 $ 157,572,086
Change in Net Assets Resulting from Operations                
Net investment loss (4,031,135) (23,354,684) (3,978,492) (3,454,815) (3,722,160) (3,661,769) (31,364,311) (10,838,744)
Net realized gain/(loss) on investments (7,748,545) 5,049,520 890,513 5,196,799 21,212,611 (17,951) (1,808,512) 26,391,459
Realized loss on partial repurchase (11)     (15,873) (11) (15,873)
Net change in unrealized appreciation/(depreciation) of investments (9,378,815) (398,509) 158,724,039 5,675,109 44,837,619 2,888,878 148,946,715 53,401,606
Net Change in Net Assets Resulting from Operations (21,158,506) (18,703,673) 155,636,060 7,417,093 62,328,070 (806,715) 115,773,881 68,938,448
Change in Net Assets Resulting from Capital Transactions                
Stock-based compensation 11,085,473 599,271 375,730 277,370 38,784    
Net Change in Net Assets Resulting from Capital Transactions 13,009,077 599,271 10,932,367 277,370 38,784    
Total Change in Net Assets (21,158,506) (5,694,596) 156,235,331 12,377,433 62,605,440 (767,931)    
Net Assets at ending of period 334,698,480 355,856,986 $ 361,551,582 231,787,028 219,409,595 $ 156,804,155 $ 334,698,480 $ 231,787,028
Shares repurchased for tax withholdings on vesting of employee equity awards   (5,897,743)          
Conversion of 6.50% Convertible Notes due 2029   $ 7,821,347          
Distributions                
Dividends declared     (5,972,027)        
Total Distributions     (5,972,027)        
Issuance of common stock from public offering     $ 10,556,637        
Capital Share Activity                
Shares outstanding at beginning of year     25,377,756     23,601,566 25,377,756 23,601,566
Issuance of common stock from public offering, shares             1,230,984
Issuance of common stock under restricted stock plan, shares [1]             2,962 286,541
Issuance of common stock from conversion of 6.50% Convertible Notes due 2029             1,092,504
Shares outstanding at end of period 26,473,222     25,119,091     26,473,222 25,119,091
[1] Refer to “Note 11 — Stock-Based Compensation” for more detail.